BOULDER, Colo., March 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
|
Event: |
Cowen and Company Annual Healthcare Conference |
|
Presenter: |
Ron Squarer, Chief Executive Officer |
|
Date: |
Wednesday, March 8, 2017 |
|
Time: |
10:00 a.m. Eastern Time |
|
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven registration studies are currently advancing related to six cancer drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
SOURCE Array BioPharma Inc.
